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THE EFFECTS OF PENTAZOCINE AND TRIPELENNAMINE
ON ANALGESIA AND LOCOMOTION

James Philip Cleary, Ph.D.
Western Michigan University, 1982

The effects of pentazocine and tripelennamine, alone and in
combination, were assessed on measures of analgesia (hot plate
test) and locomotion (open field) in rats and mice.

In Experi

ment 1, the combination of pentazocine cind tripelennamine was
found to produce analgesia at doses which were not analgesic when
the drugs were given alone.

This combination also reestablished

analgesia in subjects made tolerant to pentazocine’s effects.

In

Experiment 2, development of tolerance to the analgesic effects
of pentazocine was delayed by addition of tripelennamine.

In

Experiment 3, locomotion was decreased by pentazocine at the
highest dose.

A similar reduction was produced by combining tri

pelennamine with lower doses of pentazocine.

The relation of

these data to the rising popularity of pentazocine and tripelen
namine abuse is discussed.
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INTRODUCTION

Abuse of the analgesic pentazocine in combination with the anti
histamine tripelennamine has recently received the concerned attention
of many investigators.

This combination is known on the illicit drug

market as "T's and blues", a slang name derived from the trade name
for pentazocine, Talwin (Winthrope Laboratories, New York, NY), and
from the light blue color of the tripelennamine tablet.

The mixture

apparently was first used by addicts as a substitute for more expen
sive, scarce, or poor quality heroin.

Now, however, many addicts

apparently prefer T ’s and blues to street quality narcotics
(Showalter, 1980).
At present, the abuse of this drug combintation is centered in
the metropolitan areas of the midwestem United States (Poklis &
VJhyatt, 1980; Showalter, 1980; Wadley S Stillie, 1980).

Lehmyer and

Steingold (1980) studied changes in abuse patterns among veterans
living in Chicago.

These authors found a sevenfold increase in

pentazocine use between 1975 and 1978; over 97% of pentazocine users
added tripelennamine. to their injection solutions.

Similar increases

in the use of this combination have been reported in other areas
(Poklis & Whyatt, 1980), and the National Institute of Drug Abuse
warned local drug clinics in 1979 of increased abuse.
When pentazocine was first marketed as an analgesic in 1967,
initial reports indicated that the drug had an extremely low abuse
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potential (Kelly, 1977).

Most reports

claimed that pentazocine's

mixed agonist-antagonist nature would prevent its abuse by morphine
or heroin addicts (see Chambers, Inciardi, s Stephens, 1971, for a
review of early pentazocine use).

Indeed, pentazocine may induce

symptoms of narcotic withdrawal in morphine-dependent subjects
(e.g., Bhargava, 1981).
Two years after the World Health Organization (1966) proclaimed
that there was little likelihood of pentazocine abuse, and one year
after its introduction onto the market, the first reports of penta
zocine dependence were issued by Winthrope Laboratories (1967),
pentazocine's m^ufacturer. Early reports indicated abuse was
largely

limited to physicians and patients iatrogenically addicted

(Chambers, et al., 1971).

Documented cases of pentazocine abuse

increased throughout the 1970's (Levy, Brown, S Halikas, 1972;
Swanson, Weddige, & Morse, 1973).
Tripelennamine, although not known to produce dependence, has
shown some abuse potential for several years-

O'Driscoll and Lindley

(1957) reported tripelennamine abuse by "street addicts" over 20
years ago.

Although the antihistamine was sometimes used alone,

often the drug was combined with heroin or paregoric in a combination
known as "blue velvet" (Wadley & Stillie, 1980).

It is of some

interest that a brief attempt to use tripelennamine to treat morphine
withdrawal during the post World War II years (Kells, 1948) may have,
introduced tripelennamine to street users.

Whatever the original

impetus, abuse of tripelennamine alone or in polydrug combinations,
was relatively minor until the recent rise in popularity of T's and
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The main factor involved in the rise in popularity of T's and
blues may be availability.

Pentazocine was originally classified as

a narcotic antagonist similar to nalorphine.

It was not until 1978

that it was reclassified under the Controlled Substances Act, and
then placed in the least restrictive category.

Illinois has recently

reclassified the drug, giving it Schedule II (relatively restricted)
status.

Whether other states will follow suit is unclear; at present,

pentazocine is relatively easy to obtain.

Tripelennamine is a common

and effective antihistamine obtainable in tablet form by prescription
or over-the-counter as a topical ointment.
.When used illicitly, both drugs are usually obtained in tablet
form.

Most commonly, the tablets are in doses of 50 mg pentazocine

(Talwin, Winthrope Laboratories) and 50 mg tripelennamine (Pyribenzamine, Geigy Pharmaceuticals, Ardsley, NY).
in water in a ratio

Users dissolve the tablets

of 2 pentazocine tablets to 1 tripelennamine

tablet (3:1 or 8:3 ratios are also popular), strain the solution
through cotton, and inject it intravenously.

The preferred ratio

varies among users and is apparently adjusted until the desired
euphoric effects are produced.

Estimates of the doses used vary from

200 to 600 mg pentazincone and 100 to 250 mg tripelennamine per
injection (Poklis s Whyatt, 1980).
Use of the tablet form of either drug for intravenous injections
may produce severe problems.

Inflamation, absecesses, and subcutane

ous ulcers are frequently reported (Poklis & Whyatt, 1980).

A more

serious problem stems from the insoluble "talc" (magnesium silicate)
used in preparation of the oral form of both drugs.

This talc is
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seldom completely filtered by the cotton and eventually forms
granuloma in the lungs, causing pulmonary occlusions, thrombosis,
thrombophlebitis, and pulmonary hypertension (Butch, Yokel, Sigell,
Hanenson, S Nelson, 1979; Lahmeyer s Steingold, 1980).

Other

problems associated with nonsterile injections (e.g., hepatitis)
may also occur.
In addition, both drugs produce undesirable side effects.

Along

with physical dependence, pentazocine may produce nausea, vomiting,
and severe headaches.

Tripelennamine is known to produce convul

sions, loss of consciousness, and seizures at high doses
Whyatt, 1980).

(Poklis &

The most frequent psychological conplications

reported for pentazocine and tripelennamine abuse involve dysphoria,
paranoia, disorientation, hallucinations, and depression (Showalter,
1980).
The severity of the complications associated with abuse of tri
pelennamine and pentazocine combinations would not be expected from
early pharmacological reports of their action.

Tripelennamine, (2-

[benzyl]2- (dimethylamino)ethyl[-amino]pyridine) , is an antihistamine
of the ethylenediamine class.

Such antihistamines are primary

blockers (competitive antagonists) of the effects of histamine on
receptors.

Tripelennamine blocks histamine's ability to control

smooth muscle, dilate capillaries, constrict bronchial tubes, and
increase capillary permeability (Douglas, 1980).

The drug may produce

both central nervous system sedation (high doses) or excitation (lowmoderate doses).

The mechanism for these effects is unlcnown.

Although its primary effect at

receptors is only documented in the
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periphery, suspected central nervous system effects involve
colinergic blocking and gamma aminobutyric acid (GABA) blocking
actions (Douglas, 1980).
Pentazocine [l,2,3,4,5,6-hexahydro-6 ll-dimethly-3-(methyl-2buteryl)-2, 6-methano-3-benzazocine-8ol], is an analgesic of the
benzomorphan series.

It is a mixed narcotic agonist-antagonist.

As an agonist, it appears to be about 30% as effective as morphine,
at least with respect to analgesic actions.

The antagonist proper

ties of pentazocine are sufficient to precipitate abstinence symptoms
in morphine-dependent subjects (Bhargava, 1981).
Pentazocine has generated modest interest among behavioral
pharmacologists.

In 1972, Hoffimeister and Schlichting reported that

rhesus monkeys would self-administer pentazocine.
._

By this time, some

cases of dependence in humans had already been reported (Chambers, et
al., 1971).

Pentazocine has also been shown to be analgesic in

nonhumans (Dykstra & McMillan, 1974), and to serve as a discriminative
stimulus (Kuhn, Greenberg, & Appel, 1976).

Both of these effects

appear only at doses that are two to three time greater than similarly
effective doses of morphine.
The behavioral effects of pentazocine and tripelennamine combina
tions have been little studied in nonhumans.

Bhargava (1981) found

that the combination blocked some symptoms of narcotic abstinence in
mice, while Waller, Katz, and Morris (1980) reported that tripelenna
mine increased the lethality of pentazocine in this species.

The

primary purpose of the present studies was to determine how the
analgesic actions of pentazocine in rats are affected by the addition
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of tripelennamine.

Analgesia is an important and readily measured

response to pentazocine, and determining how it is affected by the
addition of tripelennamine may provide a readily quantifiable
measure of how these drugs interact to affect behavior.

Analyzing

the basic behavioral effects of the drugs is prerequisite to
understanding their abuse by humans.
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CHAPTER II

EXPERIMENT I

In E^^riment I, a hot plate assay of analgesia (Woolfe S
Macdonald, 1944) was used to evaluate the effects of superimposing
acute tripelennamine injections over a chronic pentazocine regimen.
Three doses of pentazocine (10, 20, and 30 mg/kg) were studied in
combination with three doses of tripelennamine (0.5, 5.0, and 10.0
mg/kg); the effects of these drugs and "doses alone were also deter-

Subjects

Thirty adult male rats of the Sprague-Dawley strain, bred in
the Psychology Department colony at Western Michigan University,
served as subjects.

At the start of the experiment, all rats were

approximately 9 months old and weighed 300-350 grams.
Subjects were housed in group cages (5 per cage) with free
access to food and water.

The colony room, where animals were

housed, was constantly illuminated and maintained at 24® centigrade
throughout the experiment.

Apparatus

Analgesic tests were performed on a heated plate (Chicago
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Surgical & Electrical, Co., Chicago, IL) measuring 17.0 cm by 62.5
cm.

The plate was enclosed by wooden walls on three sides and a

clear platic front viewing wall (21.0 cm high).

A 0.6 cm thick

piece of perforated hardboard, hinged to the back wall, served as a
cover for the apparatus.

The hot plate was maintained at a tenpera-

ture of 52® centigrade throughout the experiment.

The effects of three doses of tripelennamine hydrochloride (0.5,
5.0, and 10.0 mg/kg) and three doses of pentazocine lactate (10.0,
20.0, and 30.0 mg/kg) were evaluated alone and in combination.

Doses

of tripelennamine (Sigma Chemical Co., St. Louis, MO) refer to the
total salt while doses of pentazocine (purchased as Talwin from
Winthrope Laboratories) refer to the base.

Control injections of

isotonic saline (0.9%) were given on all non-drug days.

All injec

tions were given intraperitoneally at a volume of 1.0 ml/kg.

Drugs

were mixed with isotonic saline to obtain the proper concentration
for injection.

Procedure

Analgesic sessions were conducted daily.

Animals were injected

with tripelennamine, pentazocine, a combination of these two drugs,
or isotonic saline solution, and then immediately returned to their
home cages.

Thirty minutes after injection, analgesic testing was

begun by placing individual animals in the middle of the heated
plate (52® C).

The latency from contact with the plate until the
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first hind paw lick was recorded for each subject.

To minimize

tissue damage, subjects were never allowed to be in contact with
the plate for more than 30 seconds.

If a subject did not lick his

paw within 30 seconds, he was immediately removed from the plate
and a latency score of 30 seconds was recorded.
Initially, subjects were randomly assigned to one of three
groups of 10 animals each.

All groups were tested daily on the hot

plate under saline control conditions until the mean paw lick
latencies were stable over a 3-day period.

The stability criterion

was defined as a variation of less than 10%, on each given day, from
the mean of those 3 days.
When stability was reached, a dose-effect curve was obtained
for three doses of tripelennamine (0.5, 5.0, and 10.0 mg/kg).
Tripelennamine doses were given in a random order with three control
sessions between each tripelennamine dose.

Following tripelennamine

and with three more placebo sessions intervening, each group began
receiving a different daily maintenance dose of pentazocine, either
10.0,

20.0, or 30.0 mg/kg.

Daily pentazocine administration and

testing were continued until the subjects were tolerant (i.e., paw
lick latency returned to predrug control levels).

At this time,

combinations of tripelennamine and the maintenance dose of pentazo-r
cine were administered in a random

order with three sessions of

pentazocine alone interposed between each combination test.

Each

group received 0.5, 5.0, and 10.0 mg/kg doses of tripelennamine, in
combination with the maintenance dose of pentazocine, on a single
occasion.
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Combined data from all subjects produced mean paw lick latencies
of 5.7, 7.8, and 5.9 seconds at respective doses of 0.5, 5.0, and
10.0 mg/kg tripelennamine.

Although the mean latency at 5.0 mg/kg

was slightly elevated, none of these means proved significantly dif
ference from t^e saline control mean of 5.8 seconds (repeated
measures analysis of variance). Initial pentazocine administration
produced mean paw lick latencies of 5.0, 6.8, and 17.1 seconds at
does of 10.0, 20.0, and 30.0 mg/kg, respectively.

Only at 30 mg/kg

was this mean latency significantly different from that group's
saline control latency of 5.2 seconds (t^g^ = 4.85, df = 45, p<

.001).
Pentazocine was given to each group for seven consecutive ses
sions prior to the first combination with tripelennamine.

Subjects

showed stable response latencies across the final 3 days of this
period (within ± 10% of 3-day mean).
20.0,

For groups receiving 10.0,

or 30.0 mg/kg pentazocine, these respective mean latencies

were 3.8, 5.3, and 6.1 seconds, compared to respective control mean
latency on the 3 saline days just prior to combination tests.

Thus

paw lick latencies under pentazocine had returned to control levels,
demonstrating that the subjects had become tolerant to the pentazo-

Table 1 summarizes the results of combining tripelennamine with
pentazocine for each of the three groups.

These results are also

presented in Figure 1 as a percentage of the mean paw lick latency
over the final 3 days of pentazocine alone.

No combination of
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Sinnmary of the Effects of Combinations of Tripelennamine
and Pentazocine on Paw Lick Latencies

Control
Latency
Latency
^LSD
(seconds) (seconds) Control
10 mg/kg pentazocine +
.5 mg/kg tripelennamine

3.6
SEM = .26

10 mg/kg pentazocine +
5 mg/kg tripelennamine

P

4.4

121%

not significant

3.8
SEM = .34

4.2

111%

not significant

10 mg/kg pentazocine +
10 mg/kg tripelennamine

4.0
SEM = .31

5.0

125%

not significant

20 mg/kg pentazocine +
.5 mg/kg tripelennamine

5.3
SEM = .47

3.9

74%

not significant

20 mg/kg pentazocine +
5 mg/kg tripelennamine

4.5
= .32

5.6

124%

not significant

20 mg/kg pentazocine +
10 mg/kg tripelennamine

4.7
SEM = .51

8.4

178%

3.45(45) 0.0012

30 mg/kg pentazocine +
-5 mg/kg tripelennamine

6.1
= .78

6.3

103%

not significant

30 mg/kg pentazocine +
5 mg/kg tripelennamine

7.2
= .93

11.4

159%

1.88(45) 0.066

30 mg/kg pentazocine +
10 mg/kg tripelennamine

7.0
=1.4

13.3

191%

2.82(45) 0.0071
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tripelennamine with 10.0 mg/kg pentazocine produced latencies that
were significantly different from the latencies associated with that
dose of pentazocine alone.

Pentazocine at 20.0 mg/kg in combination

with 0.5, 5.0, and 10.0 mg/kg tripelennamine produced paw lick laten
cies of 3.9, 5.6, and 8.4 seconds respectively, with respective
control latencies of 5.3, 4.5, and 4.7 seconds [F = 4.44 (5.45), p <
.Oil.

At this dose of pentazocine, only the highest dose of tripel

ennamine produced a mean latency that was significantly different
from the control latency [t^^

= 3.67 (5,45) p <

.OIJ.

Planned

comparison tests yielded significance levels of p < .10, for the 5.0
mg/kg tripelennamine combination with 30.0 mg/kg pentazocine and p <
.001 for the 10.0 mg/kg tripelennamine combined with the same penta
zocine dose-

At 0.5 mg/kg tripelennamine plus 30.0 mg/kg pentazocine

the latencies were not significantly different from pentazocine alone

Paw lick latencies under combination doses are presented in
Figure 1 as a percentage of the mean of the final 3 days under penta
zocine alone.

This figure graphically emphasizes the effect of

tripelennamine upon subjects maintained on pentazocine and tolerant
to its effects.

It may be readily seen in this figure that no dose

of tripelennamine much affected latencies under the lowest dose of
pentazocine.

However, while 5.0 mg/kg tripelennamine only increased

latencies under 30.0 mg/kg pentazocine, 10.0 mg/kg tripelennamine
substantially increased paw lick latencies under both 20.0 and 30.0
mg/kg pentazocine.

At these higher doses of pentazocine, latencies

are monotonie across doses of tripelennamine.
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Paw lick latencies under combinations of pentazocine and
tripelennamine, expressed as a percentage of the mean of
the final 3 days of pentazocine maintenance.
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Discussion

Tripeleimamine, as a member of the ethylenediamine antihista
mine group, is thought to produce weak central nervous system effects.
With high doses, central nervous system sedation is apparently the
most common side effect (Hays, Johnson, & Perry, 1980).

Although such

sedation may certainly contribute to a general lessening of respon
siveness, general analgesia has not been reported as a specific '
effect

of this drug.

As expected, tripelennamine showed no analgesic

properties at the doses tested in the present study.
Pentazocine, promoted for its analgesic effects, increased paw
lick latencies at the highest dose tested, but did not produce anal
gesia at the two lower doses.

Other authors have reported analgesia

at doses comparable to these lower doses, but they employed different,
and perhaps more sensitive, procedures (e.g., Goode, Rhodes, &
Waterfall, 1979).

Under a regimen of chronic daily pentazocine

administration in the present study, subjects quickly became tolerant
to its analgesic effects (30 mg/kg pentazocine group).
The most interesting finding of this study is the analgesia pro
duced by the combination of the two drugs in subjects already
tolerant to pentazocine.

In the group receiving 20 mg/kg pentazocine,

tripelennamine at 10 mg/kg actually produced significant analgesia
when neither drug alone produced analgesia at those doses.

Further

more, paw lick latencies appeared to be a direct monotonie function
of the tripelennamine dose under 20 and 30 mg/kg of pentazocine main
tenance.

Thus, this drug combination appears to produce an analgesic

response similar to that associated with higher doses of pentazocine.
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16
Since pentazocine taken alone may exacerbate the symptoms of
narcotic abstinence, it was assumed for many years that the drug
held little potential for abuse among "street" users (Kelly, 1977).
Now, however, the abuse of pentazocine in combination with tripelen
namine has reached epidemic proportions (Lahmeyer & Steingold, 1980).
The ability of this combination to block some of the synptoms of
narcotic abstinence has previously been put forward as a rationale
for the current popularity of the mixture (Bhargava, 1981) - The
demonstration, in the present study, that tripelennamine can enhance
the major narcotic property of pentazocine (i.e., analgesia) adds a
further dimension to this analysis.
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CHAPTER III
EXPERII-ÎENT II

.
1

Experiment 1 examined the effects of pentazocine and tripelen
namine in subjects chronically exposed to pentazocine.

Under these

conditions, tripelennamine appeared to facilitate the analgesic action
of pentazocine-.

The mechanism of this facilitation is unknown.

To

clarify the relationship between these two drugs further. Experiment
2 investigated the effects of tripelennamine and pentazocine in nontolerant subjects.
In this study, drug-naive subjects were exposed to maintenance
doses of either pentazocine or a combination of pentazocine and tri
pelennamine.

This procedure allows an assessment of the initial

effect of the combination.

In addition, under daily maintenance

administrations, the course of tolerance development to pentazocine
alone and to pentazocine plus tripelennamine can be compared.

Method

Subjects

Thirty experimentally naive male rats of the Sprague-Dawley
strain, obtained from the Psychology Department colony at Western
Michigan University, served as subjects.

At the start of the experi

ment, the rats were approximately 9 months old and weighed 300-350
grams:

Subjects were housed in group cages with free access to food

and water, in a constantly illuminated room maintained at 24® centigrade.
17
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Apparatus

Analgesic tests were performed on the hot plate apparatus
described in Experiment 1.

the effects of 30.0 mg/kg pentazocine, alone and in combination
with 5.0 and 10.0 mg/kg tripelennamine, were evaluated.
were prepared as in ES^)eriment 1.

These drugs

All injections were intraperi- •

toneal and isotonic saline (0.9%) again served as the vehicle control.

Procedure

Analgesic sessions were conducted as described as in Experiment
1.

Briefly, subjects were placed on the hot plate 30 minutes after

injection and the latency to lick the hind paw was recorded.

A

maximum latency of 30 seconds was allowed for any subjects on any
given day.
Subjects were divided into 3 groups of 10 rats per group.

Each

group was first exposed to 10 sessions of analgesic testing under
control conditions, where injections of isotonic saline solution were
given.

Immediately following these sessions, one group was exposed

to 18 consecutive daily sessions in which 30.0 mg/kg pentazocine was
given.

The other two groups were treated identically, but tripelen

namine at either 5.0 or 10.0 mg/kg was added to the 30.0 mg/kg of
pentazocine.

This dose of pentazocine alone, and these combinations

of pentazocine and tripelennamine produced significant analgesia in
Experiment 1.
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Mean paw lick latencies for the first drug session were 16.5,
13.4, and 18.5 seconds for the groups that received 30.0 mg/kg
pentazocine, 30.0 mg/kg pentazocine plus 5.0 mg/kg tripelennamine,
and 30.0 mg/kg pentazocine plus 10.0 mg/kg tripelennamine, respec
tively.

None of these means were significantly different from each

other.

Mean control latencies for these groups, averaged across the

final 3 days of saline administration, were 6.3 (SEM = 0.49), 5.9
(SEM = 0.62), and 5.7 (SEM = 0.43) seconds, respectively.

Conpafisons

between drug and control means indicated that pentazocine alone, and
together with both doses of tripelennamine, produced latencies on the
first drug day that were significantly different from their control val
ues.

Obtained t ^ ^ values were t^^^ = 3.90 (df = 45) p <

.001 for

the group that received 30.0 mg/kg pentazocine, t^^^ = 2.85 (df = 45)
p < .01 for the group that received 30.0 mg/kg pentazocine plus 5.0
mg/kg tripelennamine, and t ^ ^ = 4.92 (df = 45) p <

.001 for the group

that received 30.0 mg/kg pentazocine plus 10.0 mg/kg tripelennamine.
Figure 2 shows the paw lick latencies for all three groups
during the 18 days of drug administration.

All groups showed toler

ance to the drug administrations by eventually returning to their
saline control levels.

The most interesting results presented in

Figure 2 occurred during the first 10 days.

From Days 4 through 9,

both groups receiving tripelennamine showed considerably less toler
ance than the group receiving pentazocine alone.

By the 10th day,

latencies for all 3 groups converged.
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Figure 2.

Paw lick latencies under 30 mg/kg pentazocine, alone and
in combination with 5 and 10 mg/kg tripelennamine, across
18 consecutive daily sessions. Means and SEM (brackets)
for the final 3 days under saline control conditions are
presented in the left panel.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

2

O

(03S)A0N31VH MO 11 MVd

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

22
Subjecting the data from the first 10 days of drug administra
tion to analysis of covariance (ANCOVA) resulted in an F of 2.52
(df =2,.2Q with p < .05.

Basically this may be interpreted as a

significant difference between the adjusted means of the 3 groups.
Since, in this case, the groups started out with essentially
equivalent mean latencies, the adjusted means are the same as the
sirple means; they were 9.9, 10.7, and 13.3 seconds, under 30.0 mg/kg
pentazocine, 30.0 mg/kg pentazocine plus 5.0 mg/kg tripelennamine,
and 30.0 mg/kg pentazocine plus 10.0 mg/kg tripelennamine, respec-

Discussion

As was the case in the first experiment. Experiment 2 i
that 30 mg/kg pentazocine produced significant analgesia.

From the

enhanced analgesia produced in pentazocine tolerant subjects in
Experiment 1, it might be expected that tripelennamine would also
enhance the effects of pentazocine in dxnag-naive subjects.

This was

not the case however, as there was no significant difference between
the degree of analgesia produced by pentazocine alone and that pro
duced by pentazocine plus either dose of tripelennamine.
Despite tripelennamine's

inability to enhance analgesia when

conüxined with initial pentazocine injections, the antihistamine did
affect the subsequent development of tolerance.

By Day 4, the mean

paw lick latency for the pentazocine alone group was clearly lower
than that of the two groups receiving the combination.

Not until

Day 10 does it appear that data for all three groups are again
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equivalent.

Just how tripelennamine interferes with tolerance devel

opment, or enhances analgesia in rats already tolerant to pentazocine,
is not addressed by these data.
effect

It is clear, however, that the former

is not permanent but is itself subject to tolerance.
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CHAPTER IV

EXPERIMENT III

One potential problem with interpretation of the preceeding
two experiments involves ;the validity of the hot plate test as a
measure of analgesia.

The paw lick, though a common measure of

analgesia (see Fraser & Harris, 1967, for a review), is a complex
motor movement and several variables may affect an organism’s
propensity to emit this response.

For example, reduced activity

due to ataxia or sedation could increase paw lick latencies.
Babbini, Gaiardi, and Bartoletti .(1981) have reported that pentazo
cine (30 mg/kg) suppresses motility in drug-naive rats during the
first post-injection hour, while Bhargava (1981) reported increased
ataxia due to the combined effects of pentazocine and tripeleimamine
in mice already addicted to morphine.

Thus it is possible that the

apparent analgesia evidenced in Experiments 1 and 2 is at least in
part the result of gross motor deficits.

Such a nonspecific drug

effect is certainly less interesting than a specific analgesic action.
Experiment 3 attempted to determine the contribution of gross
motor incapacities to the apparent analgesia evident in Experiments
1 and 2.

In this study, an "open field" test was used to quantify

the effects of pentazocine and tripelennamine on locomotion in the
absence of exogenous aversive stimulation.
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Subjects

One hundred sixty adult male CF-1 mice, bred in the Psychology
Department colony at Western Michigan University, served as subjects.
Subjects were housed in large cages, with 20-30 mice per cage, and
with free access to food and water.

The colony room was maintained

at 24° centigrade under constant illumination.

Apparatus

The open field was made of opaque plastic with a floor area of
60 cm by 45 cm.
field area.

Plastic walls (32 cm high) entirely enclosed the

The floor was divided, by white lines, into a grid

consisting of 30 squares.

Each square was 9.4 cm on a side.

Electromechanical equipment was used to time observation periods
and record data.

Each group of subjects received either saline (0.9%), tripelen
namine (5.0, 10.0, or 20.0 mg/kg), pentazocine (5.0, 10.0, or 20.0
mg/kg), or one of nine possible combinations of these drugs and doses.
All injections were intraperitoneal.

Injection volumes were held

constant at 10.0 ml/kg by adjusting the concentrations with isotonic
saline solution.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Procedure

On the day of testing, one-half of a group was injected with the
appropriate drug(s) and placed in a holding cage.

Twenty minutes

later, the second half of the group was injected.

This staggered

injection procedure insured that all subjects were tested at approxi
mately the same post-injection times.
Thirty minutes after injection, single subjects were removed
from the holding cage and placed in the center of the open field.
For the next three minutes one or two observers, blind in regard to
the experimental conditions, recorded the number of squares the
subject entered.

At the end of the 3-minute period the subject was

removed, the floor cleaned of feces, and another subject tested.
This procedure was repeated until all mice were tested.
On 9 of the 16 test days, two observers were used.

Interobserver

agreement was calculated by correlating the scores of the two
observers on each of these days.

Pearson product-moment correlations

ranged from r = .97 to r = .99, indicating a high degree of inter
observer agreement.

One observer was always the primary data collector

and her scoring was used as the dependent measure.

Results

Table 2 provides a summary of the results for all 16 groups
tested on the open field.

One-way analysis of variance produced an

overall significant F-value among all groups [F = 2.57(df =15, 144),
p < .01].

Under saline control conditions, mice entered an average

of 137 squares during the 3-minute observation period.

Mean squares
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Summary of Results from the Open Field Test Under
Saline, Pentazocine, Tripelennamine, and All
Combinations of the Two Drugs

Squares
Entered
(SEM)
0.9% saline

137
(13.4)

Control

■

■

5.0

tripelennamine

132
(15.9)

95.7%

not significant

10.0

tripelennamine

143
(11.4)

103.8%

not significant

20.0 . g A g tripelennamine

142
(20.3)

not significant

5.0 mg/kg pentazocine

127
(13.9)

not significant

10.0 mg/kg pentazocine

154
(10.5)

111.9%

20.0 mg/kg pentazocine

91
(11.8)

65.9%

5.0 mg/kg pentazocine +
5.0 mg/kg tripelennamine

128
(20.3)

93.3%

not significant

5-.0 mg/kg pentazocine +
10.0 mg/kg tripelennamine

96
(16.8)

70.2%

not significant

pentazocine +
tripelennamine

115
(15.4)

83.3%

not significant

pentazocine +
10.0
5.0 mg/kg tripelennamine

75.1%

not significant

(16.4)

pentazocine +
tripelennamine

135
(18.4)

98.4%

not significant

pentazocine +
^ A g tripelennamine

76
(13.9)

55.1%

tj^=2.63 p<.01

5.0
20.0

10.0

Z'Z

not significant
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Mean
Squares
Entered
(SEM)
20.0 mg/kg pentazocine +
5.0 mg/kg tripelennamine

124
(25.8)

20.0 mg/kg pentazocine +
10.0 mg/kg tripelennamine

(17.7)

20.0 mg/kg pentazocine +
20.0 mg/kg tripelennamine

(14.5)

Percent
Saline.
Control

90.0%

t___

(df = 144)

not significant

52.6%

57.3%
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entered, by groups that received 5, 10, and 20 mg/kg tripelennamine,
were 132, 143, and 142, respectively.

None of these means were sig

nificantly different from the saline control mean.

Under pentazo

cine, means were 127, 154, and 91 squares entered at respective doses
of 5, 10, and 20 mg/kg.

Planned comparison tests revealed that only

the mean at the highest dose of pentazocine was significantly differ
ent from the saline control mean [t^^^ = 1.99 (144), p <

.05].

Pentazocine at 5 mg/kg combined with 5, 10, and 20 mg/kg tri
pelennamine was associated with respective means of 128, 96, and 115
squares entered.

None of these means were significantly different

from the saline control mean, nor were they significantly different
from the pentazocine-alone mean.
At 10 mg/kg pentazocine, in combination with 5, 10, and 20 mg/kg
tripelennamine, mean number of squares entered was 103, 135, and 76,
respectively.

This final mean value was significantly different from

the saline control mean [t^^^ = 2.63 (144), p <
this dose

.01].

Interestingly,

of pentazocine increased the number of squares entered

when it was given alone.

However, when combined with 5 and 20 mg/kg

of tripelennamine, the mean number of squares was substantially
reduced.

In fact, these two dose combinations proved significantly

different from the 10 mg/kg pentazocine alone mean of 154 [t^^^ = 2.18
(144), p <

.05 and t^^^ = 3,36 (144), p <

.01].

Finally, 20 mg/kg pentazocine combined with 5, 10, and 20 mg/kg
tripelennamine was associated with respective means of 124, 72, and
78 squares entered.

Both of the latter means were significantly

different from the saline control mean, with respective planned
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p

.05.

None of the combinations of tripelennamine and 20 mg/kg

pentazocine proved significantly different from the pentazocine alone
mean of 90 squares entered.
Figure 3 presents the results of the combination of tripelenna
mine and pentazocine as a percentage of the saline control mean.
Numerical percentages are given in Table 2.

Again, mean entry values

significantly different from saline control level (100%) were found
at the highest dose of pentazocine (20 mg/kg) combined with the two
highest doses of tripelennamine (10 and 20 mg/kg) and the medium dose
of pentazocine (10 mg/kg) combined with the highest dose of tripelen
namine (20 mg/kg).

It may be seen from Figure 3 that no combination

doses increased the number of squares entered over saline levels.
When compared with pentazocine alone levels, tripelennamine further
reduced the mean number of squares entered under 7 out of 9 combina
tion doses.

However, the highest dose of pentazocine (20 mg/kg)

combined with the lowest dose of tripelennamine (5 mg/kg) did substan
tially increase locomotion over the pentazocine alone mean.

Discussion

Pentazocine has previously been reported to both increase
(Holtzman & Jewett, 1972) and decrease (Babbini et al., 1981)
mobility in rodents.

In the present study, pentazocine produced a

decrease at the highest dose but had no
lower doses.

effect on locomotion at

In general, when the drugs were combined, tripelen-

amine enhanced the locomotion decreasing effect of pentazocine.
Only when the highest pentazocine dose was combined with the lowest
tripelennamine dose did the antihistamine appear to reverse the
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Figure 3.

Number of squares entered under combinations of pentazocine
and tripelennamine, e3q>ressed as a percentage of the saline
control mean.
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locomotion decrement produced by pentazocine.

As in ES^eriment 1,

the combination of pentazocine and tripelennamine produced a signi
ficant effect at doses where neither drug was effective alone.
In general, the results of the open field test paralleled those
of Experiment 1.

This suggests that the decrease in locomotion under

combinations of tripelennamine and pentazocine could indeed have con
tributed to the increased paw lick latencies found in the first study.
However, even at the highest combination doses, the mice showed
considerable mobility in the absence of programmed aversive stimula
tion.

Thus, these motor deficits may well have been minimally disrup

tive.

In addition, the results of the present study may only be

relevant to a subject's first exposure to the combination and are not
necessarily applicable to the effect of tripelennamine in subjects
already tolerant to pentazocine.
The proportion of tripelennamine to pentazocine that is used in
a preparation has been reported to be a major factor in the desira
bility of this combination among drug abusers (Poklis & Whyatt, 1980).
The dose proportion also appears to be crucial to predicting the
combination's effect on locomotion.

None of the combinations of

tripelennamine with, a given dose of pentazocine showed a monotonie
dose-effect relationship.

Even the direction of tripelennamine's

effect, whether enhancement or reduction of mobility already reduced
by pentazocine, may not easily be predicted

from the data in Table 2.

Tripelennamine and pentazocine combinations produced significant
differences over the pentazocine-alone mean only at 10 mg/kg pentazo
cine.

At both the higher and lower doses of pentazocine, tripelenna

mine did not significantly change the locomotion decrement produced
by pentazocine alone.
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GENERAI, DISCUSSION

Dramatic increases in the abuse of pentazocine in combination
with tripelennamine have been well documented (Lahmeyer & Steingold,
1980; Poklis & Whyatt, 1980; Showalter, 1980; Wadley & Stillie, 1980).
This abuse pattern is somewhat surprising since neither drug has much
abuse potential when used alone (Kelly, 1977; Showalter, 1980).

In

interviews with drug abusers, Lahmeyer and Steingold (1980) found
that many addicts turned to this drug combination to compensate for
poor quality heroin.

Other addicts said that cost and consistency

were major advantages to the use of T's and blues.

Those with whom

the drug combination was popular reported that it is an effective
substitute for heroin and many addicts actually prefer the combina
tion (Wadley & Stillie, 1980).
Bhargava (1981) offered the only empirically based rationale for
the popularity of T's and blues.

He found that both drugs, when

given alone, actually induced narcotic abstinence in mice.

The

abstincence was qualitatively similar to that produced by the narcotic
antagonist naloxone.

The two drugs in combination enhanced some

aspects of the abstinence syndrome (ataxia, loss, of coordination,
falls), but other abstinence measures were reduced (stereotyped
junç>ing). Bhargava concluded that one possible explanation for the
use of T's and blues is their ability to inhibit some of the centrally
mediated responses precipitated by narcotic withdrawal.
35
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The enhanced analgesia produced by adding tripelennamine to
pentazocine in already tolerant subjects in Experiment 1, suggests
a different rationale for the popularity of T's and blues.
study found that the drug combination;

This

(1) produced analgesia at

doses where neither drug was analgesic alone, and (2) reestablished
analgesic levels of response in subjects tolerant to pentazocine.
This enhancement of one of pentazocine’s major narcotic properties
implies that perhaps other of the drug's narcotic properties,
including euphoria, may also be enhanced by tripelennamine.

Ei^eri-

ment 2 supported the findings of the first ejcperiment by demonstrating
that tripelennamine significantly slowed the development of tolerance
to the analgesic properties of pentazocine.
Just what mechanism might be responsible for these effects is
unclear.

Other authors have reported potent interactions between

narcotics and antihistamines.

Waller et al. (1980) reported that the

lethal dose of pentazocine could be potentiated
tripelennamine and vice versa.

lowered) by

Williams, Maickel, and Spratto (1978)

reported that, in morphine-dependent rodents, antihistamines were more
toxic than in morphine-naive animals.

The authors of both of these

studies emphasized the central nervous system stimulating properties
of antihistamines in an attenpt to account for their findings.
One explanation that would account for the data presented in
Experiments 1 and 2 involves pentazocine's mixed agonist-antagonist
nature.

If tripelennamine blocked or interfered with the antagonis

tic properties of pentazocine, then one would expect the resultant
effects to be similar to those of a higher dose of pentazocine.

Such
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effects were seen in the first two experiments. However, no single
opiate receptor model can easily accommodate such a direct antihis
tamine interaction.
Decreased motility, as seen in Experiment 3, may have confounded
the increased paw lick latencies of Experiment 1.

However, such

locomotion deficits do not easily account for the delayed tolerance
demonstrated in Experiment 2 when tripelennamine and pentazocine were
given in combination.

In addition, the aversive stimulus of the hot

plate would be expected to somewhat counteract any sedating effects.
Holtzman (1974) reported that, under a continuous avoidance schedule
where shock was the aversive stimulus, pentazocine actually increased
responding at doses comparable to those used in the present study.
Another analgesic test that does not depend so heavily on gross motor
function (e.g., tail-flick) might determine the generality of the
results obtained on the hot plate.
Results of the present study suggest three potential lines of
laboratory research.

In one, the similarity of the drug combination

to pure narcotics, such as morphine or heroin, would be studied using
procedures previously applied to the investigation of the discrimina
tive stimulus properties of drugs.

In such a procedure a subject

would be trained to make one response after injection of a drug, for
example morphine, and another response after saline injections.

Once

this behavior is well established, periodic test doses of tripelen
namine, pentazocine, and their combination, would be administered.
Proportions of morphine-appropriate responses under the various test
doses would reveal tripelennamine ’s ability to make pentazocine more
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morphine-like and identify the dose proportions that most closely
produce morphine-like responses.
A second interesting line of research would involve testing the
hypothesis that central nervous system stimulation, due to tripelen
namine 's ability to block reuptake of norepinephrine, is responsible
for the potent interactive effects of the combination.

Central

nervous system stimulation may be blocked by pharmacological means
(e.g., anesthetics), and the effects of tripelennamine and pentazo
cine combinations in the presence of such a blockade could be compared
to their effects in its absence.

The contribution of central nervous

arousal .to the action of the drugs could thus be assessed.
Finally, self-administration procedures could be used to deter
mine the most reinforcing ratio of pentazocine to tripelennamine.
This procedure could conpare the reinforcing efficacy of various
tripelennamine plus pentazocine combinations with that of morphine or
heroin.

Such information may provide a further understanding of the

factors responsible for the dramatic increase in the abuse of tripelen
namine and pentazocine combinations.

An understanding of this abuse

pattern may help predict other drug combinations that have a high
abuse potential when taken together but appear relatively safe alone.
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